Related references
Note: Only part of the references are listed.Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
Xiaoling Wang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Irisin: 'fat' or artefact
A. B. Crujeiras et al.
CLINICAL ENDOCRINOLOGY (2015)
Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy
Alba Luengo et al.
BMC BIOLOGY (2014)
Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat
Yifu Qiu et al.
CELL (2014)
Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle
Eija Pirinen et al.
CELL METABOLISM (2014)
Irisin and FGF21 Are Cold-Induced Endocrine Activators of Brown Fat Function in Humans
Paul Lee et al.
CELL METABOLISM (2014)
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Raffaele Cerutti et al.
CELL METABOLISM (2014)
Effects of the Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist GW501516 on Bone and Muscle in Ovariectomized Rats
M. P. Mosti et al.
ENDOCRINOLOGY (2014)
Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming
Jang Hyun Choi et al.
GENES & DEVELOPMENT (2014)
Effects of Resveratrol in Patients With Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure
Kian Peng Goh et al.
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM (2014)
Depression-like behaviors in mice subjected to co-treatment of high-fat diet and corticosterone are ameliorated by AICAR and exercise
Weina Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
A Novel Non-agonist Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand UHC1 Blocks PPARγ Phosphorylation by Cyclin-dependent Kinase 5 (CDK5) and Improves Insulin Sensitivity
Sun-Sil Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk
Fleur Lien et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Browning of white fat: does irisin play a role in humans?
Manuela Elsen et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
Jae Myoung Suh et al.
NATURE (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Metformin directly acts on mitochondria to alter cellular bioenergetics
Sylvia Andrzejewski et al.
CANCER & METABOLISM (2014)
Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease
Joao Tome-Carneiro et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
Zhuofeng Lin et al.
CELL METABOLISM (2013)
An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
William L. Holland et al.
CELL METABOLISM (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
Road to exercise mimetics: targeting nuclear receptors in skeletal muscle
Weiwei Fan et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men
Lasse Gliemann et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Brown and beige fat: development, function and therapeutic potential
Matthew Harms et al.
NATURE MEDICINE (2013)
FGF21 regulates metabolism and circadian behavior by acting on the nervous system
Angie L. Bookout et al.
NATURE MEDICINE (2013)
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
Andrew C. Adams et al.
PLOS ONE (2013)
Metabolic syndrome as a predictor of type2 diabetes, and its clinical interpretations and usefulness
Jeong-Ah Shin et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation
Alejandra V. Contreras et al.
ADVANCES IN NUTRITION (2013)
Lipid Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol Characteristics of Metabolic Syndrome
Eric J. Olson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
Li Qiang et al.
CELL (2012)
The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
Caries Canto et al.
CELL METABOLISM (2012)
Metformin interacts with AMPK through binding to γ subunit
Yaya Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
Johan W. Jonker et al.
NATURE (2012)
Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels
Daniel Cuevas-Ramos et al.
PLOS ONE (2012)
Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ
Wei Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
Radina Kostadinova et al.
CELL AND BIOSCIENCE (2012)
The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
Yuan Zhang et al.
ELIFE (2012)
Sensing of energy and nutrients by AMP-activated protein kinase
D. Grahame Hardie
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
Fredirick L. Mashili et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
Esther M. M. Ooi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1
Ai-Luen Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
FGF21 reloaded: challenges of a rapidly growing field
Alexei Kharitonenkov et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi et al.
NATURE (2010)
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Carles Canto et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Matthew J. Potthoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503
Mario Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2009)
AMPK and PPARδ Agonists are exercise mimetics
Vihang A. Narkar et al.
CELL (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Low-intensity exercise exerts beneficial effects on plasma lipids via PPARγ
Lee R. Butcher et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2008)
PPARα is a key regulator of hepatic FGF21
Thomas Lundasen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Sibylle Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression
Dingzhi Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Health benefits of physical activity: the evidence
DER Warburton et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
PPARδ:: a dagger in the heart of the metabolic syndrome
GD Barish et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Metabolic control through the PGC-1 family of transcription coactivators
JD Lin et al.
CELL METABOLISM (2005)
PPARs: therapeutic targets for metabolic disease
JP Berger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
JT Rodgers et al.
NATURE (2005)
Brown adipose tissue: Function and physiological significance
B Cannon et al.
PHYSIOLOGICAL REVIEWS (2004)
The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells
U Dressel et al.
MOLECULAR ENDOCRINOLOGY (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1
K Baar et al.
FASEB JOURNAL (2002)
Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction
G Boden et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T Yamauchi et al.
NATURE MEDICINE (2001)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
